drugset / Trial / NCT03892213
Pharmacokinetic Drug-Drug Interaction Study
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether benznidazole and E1224 should be administered concomitantly in patients with Chagas Disease as not enough data are available. This study aims to assess cross interactions of these two compounds.
Timeline
- Start
- 2014-10
- Primary completion
- 2014-12
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Benznidazole | Small molecule | 2.5 mg/kg | — |
| Subject | Fosravuconazole | Small molecule | 100 mg | — |